IMM 4.92% 32.0¢ immutep limited

Ann: Excellent initial Overall Survival Benefit in 1st line NSCLC, page-10

  1. 452 Posts.
    lightbulb Created with Sketch. 27
    This is key...
    Data shows efti is effective, safe and performs better than standard therapies
    Strong evidence of safely stimulating the patients’ immune response to fight cancer
    This also provides evidence that efti will most likely stimulate immune response for many diseases
    Multi-bagger
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
32.0¢
Change
0.015(4.92%)
Mkt cap ! $464.8M
Open High Low Value Volume
30.0¢ 32.5¢ 30.0¢ $1.168M 3.702M

Buyers (Bids)

No. Vol. Price($)
5 148547 32.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 51809 2
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.